| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.16 | 0.0009 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.09 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.088 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.077 | 0.1 |